Global Therapeutic Nuclear Medicines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Therapeutic Nuclear Medicines market size is predicted to grow from US$ 2270 million in 2025 to US$ 6342 million in 2031; it is expected to grow at a CAGR of 18.7% from 2025 to 2031.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Nuclear Medicines Industry Forecast” looks at past sales and reviews total world Therapeutic Nuclear Medicines sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Nuclear Medicines sales for 2025 through 2031. With Therapeutic Nuclear Medicines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Nuclear Medicines industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Nuclear Medicines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Nuclear Medicines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Nuclear Medicines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Nuclear Medicines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Nuclear Medicines.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Therapeutic Nuclear Medicines market?
What factors are driving Therapeutic Nuclear Medicines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Nuclear Medicines market opportunities vary by end market size?
How does Therapeutic Nuclear Medicines break out by Type, by Application?
The global Therapeutic Nuclear Medicines market size is predicted to grow from US$ 2270 million in 2025 to US$ 6342 million in 2031; it is expected to grow at a CAGR of 18.7% from 2025 to 2031.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Nuclear Medicines Industry Forecast” looks at past sales and reviews total world Therapeutic Nuclear Medicines sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Nuclear Medicines sales for 2025 through 2031. With Therapeutic Nuclear Medicines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Nuclear Medicines industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Nuclear Medicines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Nuclear Medicines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Nuclear Medicines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Nuclear Medicines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Nuclear Medicines.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis AG
- Bayer
- China Isotope & Radiation
- Q BioMed
- Curium Pharmaceuticals
- Jubilant DraxImage
- Dongcheng
- Lantheus
- Acrotech Biopharma.
- Progenics Pharmaceuticals
- International Isotopes
What is the 10-year outlook for the global Therapeutic Nuclear Medicines market?
What factors are driving Therapeutic Nuclear Medicines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Nuclear Medicines market opportunities vary by end market size?
How does Therapeutic Nuclear Medicines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Nuclear Medicines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Therapeutic Nuclear Medicines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Therapeutic Nuclear Medicines by Country/Region, 2020, 2024 & 2031
2.2 Therapeutic Nuclear Medicines Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Nuclear Medicines Sales by Type
2.3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2020-2025)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2020-2025)
2.4 Therapeutic Nuclear Medicines Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Nuclear Medicines Sales by Application
2.5.1 Global Therapeutic Nuclear Medicines Sale Market Share by Application (2020-2025)
2.5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Nuclear Medicines Breakdown Data by Company
3.1.1 Global Therapeutic Nuclear Medicines Annual Sales by Company (2020-2025)
3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Company (2020-2025)
3.2 Global Therapeutic Nuclear Medicines Annual Revenue by Company (2020-2025)
3.2.1 Global Therapeutic Nuclear Medicines Revenue by Company (2020-2025)
3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2020-2025)
3.3 Global Therapeutic Nuclear Medicines Sale Price by Company
3.4 Key Manufacturers Therapeutic Nuclear Medicines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Nuclear Medicines Product Location Distribution
3.4.2 Players Therapeutic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC NUCLEAR MEDICINES BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Nuclear Medicines Market Size by Geographic Region (2020-2025)
4.1.1 Global Therapeutic Nuclear Medicines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Therapeutic Nuclear Medicines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Therapeutic Nuclear Medicines Market Size by Country/Region (2020-2025)
4.2.1 Global Therapeutic Nuclear Medicines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Therapeutic Nuclear Medicines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Therapeutic Nuclear Medicines Sales Growth
4.4 APAC Therapeutic Nuclear Medicines Sales Growth
4.5 Europe Therapeutic Nuclear Medicines Sales Growth
4.6 Middle East & Africa Therapeutic Nuclear Medicines Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Nuclear Medicines Sales by Country
5.1.1 Americas Therapeutic Nuclear Medicines Sales by Country (2020-2025)
5.1.2 Americas Therapeutic Nuclear Medicines Revenue by Country (2020-2025)
5.2 Americas Therapeutic Nuclear Medicines Sales by Type (2020-2025)
5.3 Americas Therapeutic Nuclear Medicines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Nuclear Medicines Sales by Region
6.1.1 APAC Therapeutic Nuclear Medicines Sales by Region (2020-2025)
6.1.2 APAC Therapeutic Nuclear Medicines Revenue by Region (2020-2025)
6.2 APAC Therapeutic Nuclear Medicines Sales by Type (2020-2025)
6.3 APAC Therapeutic Nuclear Medicines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Nuclear Medicines by Country
7.1.1 Europe Therapeutic Nuclear Medicines Sales by Country (2020-2025)
7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2020-2025)
7.2 Europe Therapeutic Nuclear Medicines Sales by Type (2020-2025)
7.3 Europe Therapeutic Nuclear Medicines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Nuclear Medicines by Country
8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2020-2025)
8.2 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2020-2025)
8.3 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines
10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
10.4 Industry Chain Structure of Therapeutic Nuclear Medicines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Nuclear Medicines Distributors
11.3 Therapeutic Nuclear Medicines Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC NUCLEAR MEDICINES BY GEOGRAPHIC REGION
12.1 Global Therapeutic Nuclear Medicines Market Size Forecast by Region
12.1.1 Global Therapeutic Nuclear Medicines Forecast by Region (2026-2031)
12.1.2 Global Therapeutic Nuclear Medicines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Therapeutic Nuclear Medicines Forecast by Type (2026-2031)
12.7 Global Therapeutic Nuclear Medicines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 China Isotope & Radiation
13.3.1 China Isotope & Radiation Company Information
13.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 China Isotope & Radiation Main Business Overview
13.3.5 China Isotope & Radiation Latest Developments
13.4 Q BioMed
13.4.1 Q BioMed Company Information
13.4.2 Q BioMed Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Q BioMed Main Business Overview
13.4.5 Q BioMed Latest Developments
13.5 Curium Pharmaceuticals
13.5.1 Curium Pharmaceuticals Company Information
13.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Curium Pharmaceuticals Main Business Overview
13.5.5 Curium Pharmaceuticals Latest Developments
13.6 Jubilant DraxImage
13.6.1 Jubilant DraxImage Company Information
13.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jubilant DraxImage Main Business Overview
13.6.5 Jubilant DraxImage Latest Developments
13.7 Dongcheng
13.7.1 Dongcheng Company Information
13.7.2 Dongcheng Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dongcheng Main Business Overview
13.7.5 Dongcheng Latest Developments
13.8 Lantheus
13.8.1 Lantheus Company Information
13.8.2 Lantheus Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lantheus Main Business Overview
13.8.5 Lantheus Latest Developments
13.9 Acrotech Biopharma.
13.9.1 Acrotech Biopharma. Company Information
13.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Acrotech Biopharma. Main Business Overview
13.9.5 Acrotech Biopharma. Latest Developments
13.10 Progenics Pharmaceuticals
13.10.1 Progenics Pharmaceuticals Company Information
13.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Progenics Pharmaceuticals Main Business Overview
13.10.5 Progenics Pharmaceuticals Latest Developments
13.11 International Isotopes
13.11.1 International Isotopes Company Information
13.11.2 International Isotopes Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 International Isotopes Main Business Overview
13.11.5 International Isotopes Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Therapeutic Nuclear Medicines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Therapeutic Nuclear Medicines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Radium-223
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Iodine-131
Table 6. Major Players of Other
Table 7. GlobalTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 8. GlobalTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Table 9. GlobalTherapeutic Nuclear Medicines Revenue byType (2020-2025) & ($ million)
Table 10. GlobalTherapeutic Nuclear Medicines Revenue Market Share byType (2020-2025)
Table 11. GlobalTherapeutic Nuclear Medicines Sale Price byType (2020-2025) & (USD/Unit)
Table 12. GlobalTherapeutic Nuclear Medicines Sale by Application (2020-2025) & (K Units)
Table 13. GlobalTherapeutic Nuclear Medicines Sale Market Share by Application (2020-2025)
Table 14. GlobalTherapeutic Nuclear Medicines Revenue by Application (2020-2025) & ($ million)
Table 15. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Application (2020-2025)
Table 16. GlobalTherapeutic Nuclear Medicines Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. GlobalTherapeutic Nuclear Medicines Sales by Company (2020-2025) & (K Units)
Table 18. GlobalTherapeutic Nuclear Medicines Sales Market Share by Company (2020-2025)
Table 19. GlobalTherapeutic Nuclear Medicines Revenue by Company (2020-2025) & ($ millions)
Table 20. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Company (2020-2025)
Table 21. GlobalTherapeutic Nuclear Medicines Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key ManufacturersTherapeutic Nuclear Medicines Producing Area Distribution and Sales Area
Table 23. PlayersTherapeutic Nuclear Medicines Products Offered
Table 24.Therapeutic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. GlobalTherapeutic Nuclear Medicines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. GlobalTherapeutic Nuclear Medicines Sales Market Share Geographic Region (2020-2025)
Table 29. GlobalTherapeutic Nuclear Medicines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Geographic Region (2020-2025)
Table 31. GlobalTherapeutic Nuclear Medicines Sales by Country/Region (2020-2025) & (K Units)
Table 32. GlobalTherapeutic Nuclear Medicines Sales Market Share by Country/Region (2020-2025)
Table 33. GlobalTherapeutic Nuclear Medicines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Country/Region (2020-2025)
Table 35. AmericasTherapeutic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
Table 36. AmericasTherapeutic Nuclear Medicines Sales Market Share by Country (2020-2025)
Table 37. AmericasTherapeutic Nuclear Medicines Revenue by Country (2020-2025) & ($ millions)
Table 38. AmericasTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 39. AmericasTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 40. APACTherapeutic Nuclear Medicines Sales by Region (2020-2025) & (K Units)
Table 41. APACTherapeutic Nuclear Medicines Sales Market Share by Region (2020-2025)
Table 42. APACTherapeutic Nuclear Medicines Revenue by Region (2020-2025) & ($ millions)
Table 43. APACTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 44. APACTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 45. EuropeTherapeutic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
Table 46. EuropeTherapeutic Nuclear Medicines Revenue by Country (2020-2025) & ($ millions)
Table 47. EuropeTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 48. EuropeTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & AfricaTherapeutic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & AfricaTherapeutic Nuclear Medicines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & AfricaTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 52. Middle East & AfricaTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities ofTherapeutic Nuclear Medicines
Table 54. Key Market Challenges & Risks ofTherapeutic Nuclear Medicines
Table 55. Key IndustryTrends ofTherapeutic Nuclear Medicines
Table 56.Therapeutic Nuclear Medicines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58.Therapeutic Nuclear Medicines Distributors List
Table 59.Therapeutic Nuclear Medicines Customer List
Table 60. GlobalTherapeutic Nuclear Medicines SalesForecast by Region (2026-2031) & (K Units)
Table 61. GlobalTherapeutic Nuclear Medicines RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. AmericasTherapeutic Nuclear Medicines SalesForecast by Country (2026-2031) & (K Units)
Table 63. AmericasTherapeutic Nuclear Medicines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APACTherapeutic Nuclear Medicines SalesForecast by Region (2026-2031) & (K Units)
Table 65. APACTherapeutic Nuclear Medicines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. EuropeTherapeutic Nuclear Medicines SalesForecast by Country (2026-2031) & (K Units)
Table 67. EuropeTherapeutic Nuclear Medicines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & AfricaTherapeutic Nuclear Medicines SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & AfricaTherapeutic Nuclear Medicines RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. GlobalTherapeutic Nuclear Medicines SalesForecast byType (2026-2031) & (K Units)
Table 71. GlobalTherapeutic Nuclear Medicines RevenueForecast byType (2026-2031) & ($ millions)
Table 72. GlobalTherapeutic Nuclear Medicines SalesForecast by Application (2026-2031) & (K Units)
Table 73. GlobalTherapeutic Nuclear Medicines RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Novartis AG Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis AGTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 76. Novartis AGTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis AG Main Business
Table 78. Novartis AG Latest Developments
Table 79. Bayer Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 80. BayerTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 81. BayerTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bayer Main Business
Table 83. Bayer Latest Developments
Table 84. China Isotope & Radiation Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 85. China Isotope & RadiationTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 86. China Isotope & RadiationTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Isotope & Radiation Main Business
Table 88. China Isotope & Radiation Latest Developments
Table 89. Q BioMed Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 90. Q BioMedTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 91. Q BioMedTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Q BioMed Main Business
Table 93. Q BioMed Latest Developments
Table 94. Curium Pharmaceuticals Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 95. Curium PharmaceuticalsTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 96. Curium PharmaceuticalsTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Curium Pharmaceuticals Main Business
Table 98. Curium Pharmaceuticals Latest Developments
Table 99. Jubilant DraxImage Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 100. Jubilant DraxImageTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 101. Jubilant DraxImageTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Jubilant DraxImage Main Business
Table 103. Jubilant DraxImage Latest Developments
Table 104. Dongcheng Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 105. DongchengTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 106. DongchengTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Dongcheng Main Business
Table 108. Dongcheng Latest Developments
Table 109. Lantheus Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 110. LantheusTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 111. LantheusTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lantheus Main Business
Table 113. Lantheus Latest Developments
Table 114. Acrotech Biopharma. Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 115. Acrotech Biopharma.Therapeutic Nuclear Medicines Product Portfolios and Specifications
Table 116. Acrotech Biopharma.Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Acrotech Biopharma. Main Business
Table 118. Acrotech Biopharma. Latest Developments
Table 119. Progenics Pharmaceuticals Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 120. Progenics PharmaceuticalsTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 121. Progenics PharmaceuticalsTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Progenics Pharmaceuticals Main Business
Table 123. Progenics Pharmaceuticals Latest Developments
Table 124. International Isotopes Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 125. International IsotopesTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 126. International IsotopesTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. International Isotopes Main Business
Table 128. International Isotopes Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTherapeutic Nuclear Medicines
Figure 2.Therapeutic Nuclear Medicines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTherapeutic Nuclear Medicines Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTherapeutic Nuclear Medicines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Therapeutic Nuclear Medicines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Therapeutic Nuclear Medicines Sales Market Share by Country/Region (2024)
Figure 10.Therapeutic Nuclear Medicines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Lutetium-177
Figure 13. Product Picture of Iodine-131
Figure 14. Product Picture of Other
Figure 15. GlobalTherapeutic Nuclear Medicines Sales Market Share byType in 2025
Figure 16. GlobalTherapeutic Nuclear Medicines Revenue Market Share byType (2020-2025)
Figure 17.Therapeutic Nuclear Medicines Consumed inThyroid
Figure 18. GlobalTherapeutic Nuclear Medicines Market:Thyroid (2020-2025) & (K Units)
Figure 19.Therapeutic Nuclear Medicines Consumed in Bone Metastasis
Figure 20. GlobalTherapeutic Nuclear Medicines Market: Bone Metastasis (2020-2025) & (K Units)
Figure 21.Therapeutic Nuclear Medicines Consumed in Lymphoma
Figure 22. GlobalTherapeutic Nuclear Medicines Market: Lymphoma (2020-2025) & (K Units)
Figure 23.Therapeutic Nuclear Medicines Consumed in Other
Figure 24. GlobalTherapeutic Nuclear Medicines Market: Other (2020-2025) & (K Units)
Figure 25. GlobalTherapeutic Nuclear Medicines Sale Market Share by Application (2024)
Figure 26. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Application in 2025
Figure 27.Therapeutic Nuclear Medicines Sales by Company in 2025 (K Units)
Figure 28. GlobalTherapeutic Nuclear Medicines Sales Market Share by Company in 2025
Figure 29.Therapeutic Nuclear Medicines Revenue by Company in 2025 ($ millions)
Figure 30. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Company in 2025
Figure 31. GlobalTherapeutic Nuclear Medicines Sales Market Share by Geographic Region (2020-2025)
Figure 32. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Geographic Region in 2025
Figure 33. AmericasTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 34. AmericasTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 35. APACTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 36. APACTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 37. EuropeTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 38. EuropeTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 39. Middle East & AfricaTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 40. Middle East & AfricaTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 41. AmericasTherapeutic Nuclear Medicines Sales Market Share by Country in 2025
Figure 42. AmericasTherapeutic Nuclear Medicines Revenue Market Share by Country (2020-2025)
Figure 43. AmericasTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 44. AmericasTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 45. United StatesTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 46. CanadaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 47. MexicoTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 48. BrazilTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 49. APACTherapeutic Nuclear Medicines Sales Market Share by Region in 2025
Figure 50. APACTherapeutic Nuclear Medicines Revenue Market Share by Region (2020-2025)
Figure 51. APACTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 52. APACTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 53. ChinaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 54. JapanTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 55. South KoreaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast AsiaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 57. IndiaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 58. AustraliaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwanTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 60. EuropeTherapeutic Nuclear Medicines Sales Market Share by Country in 2025
Figure 61. EuropeTherapeutic Nuclear Medicines Revenue Market Share by Country (2020-2025)
Figure 62. EuropeTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 63. EuropeTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 64. GermanyTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 65.FranceTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 66. UKTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 67. ItalyTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 68. RussiaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & AfricaTherapeutic Nuclear Medicines Sales Market Share by Country (2020-2025)
Figure 70. Middle East & AfricaTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 71. Middle East & AfricaTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 72. EgyptTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 73. South AfricaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 74. IsraelTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 75.TurkeyTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC CountriesTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis ofTherapeutic Nuclear Medicines in 2025
Figure 78. Manufacturing Process Analysis ofTherapeutic Nuclear Medicines
Figure 79. Industry Chain Structure ofTherapeutic Nuclear Medicines
Figure 80. Channels of Distribution
Figure 81. GlobalTherapeutic Nuclear Medicines Sales MarketForecast by Region (2026-2031)
Figure 82. GlobalTherapeutic Nuclear Medicines Revenue Market ShareForecast by Region (2026-2031)
Figure 83. GlobalTherapeutic Nuclear Medicines Sales Market ShareForecast byType (2026-2031)
Figure 84. GlobalTherapeutic Nuclear Medicines Revenue Market ShareForecast byType (2026-2031)
Figure 85. GlobalTherapeutic Nuclear Medicines Sales Market ShareForecast by Application (2026-2031)
Figure 86. GlobalTherapeutic Nuclear Medicines Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Nuclear Medicines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Therapeutic Nuclear Medicines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Therapeutic Nuclear Medicines by Country/Region, 2020, 2024 & 2031
2.2 Therapeutic Nuclear Medicines Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Nuclear Medicines Sales by Type
2.3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2020-2025)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2020-2025)
2.4 Therapeutic Nuclear Medicines Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Nuclear Medicines Sales by Application
2.5.1 Global Therapeutic Nuclear Medicines Sale Market Share by Application (2020-2025)
2.5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Nuclear Medicines Breakdown Data by Company
3.1.1 Global Therapeutic Nuclear Medicines Annual Sales by Company (2020-2025)
3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Company (2020-2025)
3.2 Global Therapeutic Nuclear Medicines Annual Revenue by Company (2020-2025)
3.2.1 Global Therapeutic Nuclear Medicines Revenue by Company (2020-2025)
3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2020-2025)
3.3 Global Therapeutic Nuclear Medicines Sale Price by Company
3.4 Key Manufacturers Therapeutic Nuclear Medicines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Nuclear Medicines Product Location Distribution
3.4.2 Players Therapeutic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC NUCLEAR MEDICINES BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Nuclear Medicines Market Size by Geographic Region (2020-2025)
4.1.1 Global Therapeutic Nuclear Medicines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Therapeutic Nuclear Medicines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Therapeutic Nuclear Medicines Market Size by Country/Region (2020-2025)
4.2.1 Global Therapeutic Nuclear Medicines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Therapeutic Nuclear Medicines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Therapeutic Nuclear Medicines Sales Growth
4.4 APAC Therapeutic Nuclear Medicines Sales Growth
4.5 Europe Therapeutic Nuclear Medicines Sales Growth
4.6 Middle East & Africa Therapeutic Nuclear Medicines Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Nuclear Medicines Sales by Country
5.1.1 Americas Therapeutic Nuclear Medicines Sales by Country (2020-2025)
5.1.2 Americas Therapeutic Nuclear Medicines Revenue by Country (2020-2025)
5.2 Americas Therapeutic Nuclear Medicines Sales by Type (2020-2025)
5.3 Americas Therapeutic Nuclear Medicines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Nuclear Medicines Sales by Region
6.1.1 APAC Therapeutic Nuclear Medicines Sales by Region (2020-2025)
6.1.2 APAC Therapeutic Nuclear Medicines Revenue by Region (2020-2025)
6.2 APAC Therapeutic Nuclear Medicines Sales by Type (2020-2025)
6.3 APAC Therapeutic Nuclear Medicines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Nuclear Medicines by Country
7.1.1 Europe Therapeutic Nuclear Medicines Sales by Country (2020-2025)
7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2020-2025)
7.2 Europe Therapeutic Nuclear Medicines Sales by Type (2020-2025)
7.3 Europe Therapeutic Nuclear Medicines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Nuclear Medicines by Country
8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2020-2025)
8.2 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2020-2025)
8.3 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines
10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
10.4 Industry Chain Structure of Therapeutic Nuclear Medicines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Nuclear Medicines Distributors
11.3 Therapeutic Nuclear Medicines Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC NUCLEAR MEDICINES BY GEOGRAPHIC REGION
12.1 Global Therapeutic Nuclear Medicines Market Size Forecast by Region
12.1.1 Global Therapeutic Nuclear Medicines Forecast by Region (2026-2031)
12.1.2 Global Therapeutic Nuclear Medicines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Therapeutic Nuclear Medicines Forecast by Type (2026-2031)
12.7 Global Therapeutic Nuclear Medicines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 China Isotope & Radiation
13.3.1 China Isotope & Radiation Company Information
13.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 China Isotope & Radiation Main Business Overview
13.3.5 China Isotope & Radiation Latest Developments
13.4 Q BioMed
13.4.1 Q BioMed Company Information
13.4.2 Q BioMed Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Q BioMed Main Business Overview
13.4.5 Q BioMed Latest Developments
13.5 Curium Pharmaceuticals
13.5.1 Curium Pharmaceuticals Company Information
13.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Curium Pharmaceuticals Main Business Overview
13.5.5 Curium Pharmaceuticals Latest Developments
13.6 Jubilant DraxImage
13.6.1 Jubilant DraxImage Company Information
13.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jubilant DraxImage Main Business Overview
13.6.5 Jubilant DraxImage Latest Developments
13.7 Dongcheng
13.7.1 Dongcheng Company Information
13.7.2 Dongcheng Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dongcheng Main Business Overview
13.7.5 Dongcheng Latest Developments
13.8 Lantheus
13.8.1 Lantheus Company Information
13.8.2 Lantheus Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lantheus Main Business Overview
13.8.5 Lantheus Latest Developments
13.9 Acrotech Biopharma.
13.9.1 Acrotech Biopharma. Company Information
13.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Acrotech Biopharma. Main Business Overview
13.9.5 Acrotech Biopharma. Latest Developments
13.10 Progenics Pharmaceuticals
13.10.1 Progenics Pharmaceuticals Company Information
13.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Progenics Pharmaceuticals Main Business Overview
13.10.5 Progenics Pharmaceuticals Latest Developments
13.11 International Isotopes
13.11.1 International Isotopes Company Information
13.11.2 International Isotopes Therapeutic Nuclear Medicines Product Portfolios and Specifications
13.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 International Isotopes Main Business Overview
13.11.5 International Isotopes Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Therapeutic Nuclear Medicines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Therapeutic Nuclear Medicines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Radium-223
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Iodine-131
Table 6. Major Players of Other
Table 7. GlobalTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 8. GlobalTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Table 9. GlobalTherapeutic Nuclear Medicines Revenue byType (2020-2025) & ($ million)
Table 10. GlobalTherapeutic Nuclear Medicines Revenue Market Share byType (2020-2025)
Table 11. GlobalTherapeutic Nuclear Medicines Sale Price byType (2020-2025) & (USD/Unit)
Table 12. GlobalTherapeutic Nuclear Medicines Sale by Application (2020-2025) & (K Units)
Table 13. GlobalTherapeutic Nuclear Medicines Sale Market Share by Application (2020-2025)
Table 14. GlobalTherapeutic Nuclear Medicines Revenue by Application (2020-2025) & ($ million)
Table 15. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Application (2020-2025)
Table 16. GlobalTherapeutic Nuclear Medicines Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. GlobalTherapeutic Nuclear Medicines Sales by Company (2020-2025) & (K Units)
Table 18. GlobalTherapeutic Nuclear Medicines Sales Market Share by Company (2020-2025)
Table 19. GlobalTherapeutic Nuclear Medicines Revenue by Company (2020-2025) & ($ millions)
Table 20. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Company (2020-2025)
Table 21. GlobalTherapeutic Nuclear Medicines Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key ManufacturersTherapeutic Nuclear Medicines Producing Area Distribution and Sales Area
Table 23. PlayersTherapeutic Nuclear Medicines Products Offered
Table 24.Therapeutic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. GlobalTherapeutic Nuclear Medicines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. GlobalTherapeutic Nuclear Medicines Sales Market Share Geographic Region (2020-2025)
Table 29. GlobalTherapeutic Nuclear Medicines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Geographic Region (2020-2025)
Table 31. GlobalTherapeutic Nuclear Medicines Sales by Country/Region (2020-2025) & (K Units)
Table 32. GlobalTherapeutic Nuclear Medicines Sales Market Share by Country/Region (2020-2025)
Table 33. GlobalTherapeutic Nuclear Medicines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Country/Region (2020-2025)
Table 35. AmericasTherapeutic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
Table 36. AmericasTherapeutic Nuclear Medicines Sales Market Share by Country (2020-2025)
Table 37. AmericasTherapeutic Nuclear Medicines Revenue by Country (2020-2025) & ($ millions)
Table 38. AmericasTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 39. AmericasTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 40. APACTherapeutic Nuclear Medicines Sales by Region (2020-2025) & (K Units)
Table 41. APACTherapeutic Nuclear Medicines Sales Market Share by Region (2020-2025)
Table 42. APACTherapeutic Nuclear Medicines Revenue by Region (2020-2025) & ($ millions)
Table 43. APACTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 44. APACTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 45. EuropeTherapeutic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
Table 46. EuropeTherapeutic Nuclear Medicines Revenue by Country (2020-2025) & ($ millions)
Table 47. EuropeTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 48. EuropeTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & AfricaTherapeutic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & AfricaTherapeutic Nuclear Medicines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & AfricaTherapeutic Nuclear Medicines Sales byType (2020-2025) & (K Units)
Table 52. Middle East & AfricaTherapeutic Nuclear Medicines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities ofTherapeutic Nuclear Medicines
Table 54. Key Market Challenges & Risks ofTherapeutic Nuclear Medicines
Table 55. Key IndustryTrends ofTherapeutic Nuclear Medicines
Table 56.Therapeutic Nuclear Medicines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58.Therapeutic Nuclear Medicines Distributors List
Table 59.Therapeutic Nuclear Medicines Customer List
Table 60. GlobalTherapeutic Nuclear Medicines SalesForecast by Region (2026-2031) & (K Units)
Table 61. GlobalTherapeutic Nuclear Medicines RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. AmericasTherapeutic Nuclear Medicines SalesForecast by Country (2026-2031) & (K Units)
Table 63. AmericasTherapeutic Nuclear Medicines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APACTherapeutic Nuclear Medicines SalesForecast by Region (2026-2031) & (K Units)
Table 65. APACTherapeutic Nuclear Medicines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. EuropeTherapeutic Nuclear Medicines SalesForecast by Country (2026-2031) & (K Units)
Table 67. EuropeTherapeutic Nuclear Medicines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & AfricaTherapeutic Nuclear Medicines SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & AfricaTherapeutic Nuclear Medicines RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. GlobalTherapeutic Nuclear Medicines SalesForecast byType (2026-2031) & (K Units)
Table 71. GlobalTherapeutic Nuclear Medicines RevenueForecast byType (2026-2031) & ($ millions)
Table 72. GlobalTherapeutic Nuclear Medicines SalesForecast by Application (2026-2031) & (K Units)
Table 73. GlobalTherapeutic Nuclear Medicines RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Novartis AG Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis AGTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 76. Novartis AGTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis AG Main Business
Table 78. Novartis AG Latest Developments
Table 79. Bayer Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 80. BayerTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 81. BayerTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bayer Main Business
Table 83. Bayer Latest Developments
Table 84. China Isotope & Radiation Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 85. China Isotope & RadiationTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 86. China Isotope & RadiationTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Isotope & Radiation Main Business
Table 88. China Isotope & Radiation Latest Developments
Table 89. Q BioMed Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 90. Q BioMedTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 91. Q BioMedTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Q BioMed Main Business
Table 93. Q BioMed Latest Developments
Table 94. Curium Pharmaceuticals Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 95. Curium PharmaceuticalsTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 96. Curium PharmaceuticalsTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Curium Pharmaceuticals Main Business
Table 98. Curium Pharmaceuticals Latest Developments
Table 99. Jubilant DraxImage Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 100. Jubilant DraxImageTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 101. Jubilant DraxImageTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Jubilant DraxImage Main Business
Table 103. Jubilant DraxImage Latest Developments
Table 104. Dongcheng Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 105. DongchengTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 106. DongchengTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Dongcheng Main Business
Table 108. Dongcheng Latest Developments
Table 109. Lantheus Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 110. LantheusTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 111. LantheusTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lantheus Main Business
Table 113. Lantheus Latest Developments
Table 114. Acrotech Biopharma. Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 115. Acrotech Biopharma.Therapeutic Nuclear Medicines Product Portfolios and Specifications
Table 116. Acrotech Biopharma.Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Acrotech Biopharma. Main Business
Table 118. Acrotech Biopharma. Latest Developments
Table 119. Progenics Pharmaceuticals Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 120. Progenics PharmaceuticalsTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 121. Progenics PharmaceuticalsTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Progenics Pharmaceuticals Main Business
Table 123. Progenics Pharmaceuticals Latest Developments
Table 124. International Isotopes Basic Information,Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors
Table 125. International IsotopesTherapeutic Nuclear Medicines Product Portfolios and Specifications
Table 126. International IsotopesTherapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. International Isotopes Main Business
Table 128. International Isotopes Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTherapeutic Nuclear Medicines
Figure 2.Therapeutic Nuclear Medicines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTherapeutic Nuclear Medicines Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTherapeutic Nuclear Medicines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Therapeutic Nuclear Medicines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Therapeutic Nuclear Medicines Sales Market Share by Country/Region (2024)
Figure 10.Therapeutic Nuclear Medicines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Lutetium-177
Figure 13. Product Picture of Iodine-131
Figure 14. Product Picture of Other
Figure 15. GlobalTherapeutic Nuclear Medicines Sales Market Share byType in 2025
Figure 16. GlobalTherapeutic Nuclear Medicines Revenue Market Share byType (2020-2025)
Figure 17.Therapeutic Nuclear Medicines Consumed inThyroid
Figure 18. GlobalTherapeutic Nuclear Medicines Market:Thyroid (2020-2025) & (K Units)
Figure 19.Therapeutic Nuclear Medicines Consumed in Bone Metastasis
Figure 20. GlobalTherapeutic Nuclear Medicines Market: Bone Metastasis (2020-2025) & (K Units)
Figure 21.Therapeutic Nuclear Medicines Consumed in Lymphoma
Figure 22. GlobalTherapeutic Nuclear Medicines Market: Lymphoma (2020-2025) & (K Units)
Figure 23.Therapeutic Nuclear Medicines Consumed in Other
Figure 24. GlobalTherapeutic Nuclear Medicines Market: Other (2020-2025) & (K Units)
Figure 25. GlobalTherapeutic Nuclear Medicines Sale Market Share by Application (2024)
Figure 26. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Application in 2025
Figure 27.Therapeutic Nuclear Medicines Sales by Company in 2025 (K Units)
Figure 28. GlobalTherapeutic Nuclear Medicines Sales Market Share by Company in 2025
Figure 29.Therapeutic Nuclear Medicines Revenue by Company in 2025 ($ millions)
Figure 30. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Company in 2025
Figure 31. GlobalTherapeutic Nuclear Medicines Sales Market Share by Geographic Region (2020-2025)
Figure 32. GlobalTherapeutic Nuclear Medicines Revenue Market Share by Geographic Region in 2025
Figure 33. AmericasTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 34. AmericasTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 35. APACTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 36. APACTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 37. EuropeTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 38. EuropeTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 39. Middle East & AfricaTherapeutic Nuclear Medicines Sales 2020-2025 (K Units)
Figure 40. Middle East & AfricaTherapeutic Nuclear Medicines Revenue 2020-2025 ($ millions)
Figure 41. AmericasTherapeutic Nuclear Medicines Sales Market Share by Country in 2025
Figure 42. AmericasTherapeutic Nuclear Medicines Revenue Market Share by Country (2020-2025)
Figure 43. AmericasTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 44. AmericasTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 45. United StatesTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 46. CanadaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 47. MexicoTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 48. BrazilTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 49. APACTherapeutic Nuclear Medicines Sales Market Share by Region in 2025
Figure 50. APACTherapeutic Nuclear Medicines Revenue Market Share by Region (2020-2025)
Figure 51. APACTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 52. APACTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 53. ChinaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 54. JapanTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 55. South KoreaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast AsiaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 57. IndiaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 58. AustraliaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwanTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 60. EuropeTherapeutic Nuclear Medicines Sales Market Share by Country in 2025
Figure 61. EuropeTherapeutic Nuclear Medicines Revenue Market Share by Country (2020-2025)
Figure 62. EuropeTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 63. EuropeTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 64. GermanyTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 65.FranceTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 66. UKTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 67. ItalyTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 68. RussiaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & AfricaTherapeutic Nuclear Medicines Sales Market Share by Country (2020-2025)
Figure 70. Middle East & AfricaTherapeutic Nuclear Medicines Sales Market Share byType (2020-2025)
Figure 71. Middle East & AfricaTherapeutic Nuclear Medicines Sales Market Share by Application (2020-2025)
Figure 72. EgyptTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 73. South AfricaTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 74. IsraelTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 75.TurkeyTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC CountriesTherapeutic Nuclear Medicines Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis ofTherapeutic Nuclear Medicines in 2025
Figure 78. Manufacturing Process Analysis ofTherapeutic Nuclear Medicines
Figure 79. Industry Chain Structure ofTherapeutic Nuclear Medicines
Figure 80. Channels of Distribution
Figure 81. GlobalTherapeutic Nuclear Medicines Sales MarketForecast by Region (2026-2031)
Figure 82. GlobalTherapeutic Nuclear Medicines Revenue Market ShareForecast by Region (2026-2031)
Figure 83. GlobalTherapeutic Nuclear Medicines Sales Market ShareForecast byType (2026-2031)
Figure 84. GlobalTherapeutic Nuclear Medicines Revenue Market ShareForecast byType (2026-2031)
Figure 85. GlobalTherapeutic Nuclear Medicines Sales Market ShareForecast by Application (2026-2031)
Figure 86. GlobalTherapeutic Nuclear Medicines Revenue Market ShareForecast by Application (2026-2031)
